Spotlight
Money Desk
Obituaries
Classifieds
Families First
News
Weather
Specialists
Sports
Business
Opinion
Consumer
Health
Life
Out & About
Login
Recommended
The top July 4 fireworks, festivals, and food trucks in the Triangle + Maps
Recommended
Do these things indoors and out to keep your home cool in summer heat
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
Gold
Crude Oil
Local Stocks
WRALTechWire 30
WRALTechWire 30
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Biogen Idec
(NQ:
BIIB
)
223.65
-2.81 (-1.24%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Jun 18, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Biogen Idec
< Previous
1
2
3
4
5
6
7
8
9
...
38
39
Next >
The 3 Best Healthcare Stocks to Buy in June 2024
June 15, 2024
Aging populations and changing lifestyles mean healthcare is a secular story that these best healthcare stocks to buy will capitalize on.
Via
InvestorPlace
4 Best Stocks to Buy and 3 Best Stocks to Sell: June 2024
June 12, 2024
Consider making moves in these securities, each of which has news that is impacting their share price either positively or negatively.
Via
InvestorPlace
Eli Lilly's Donanemab Gains Favorable FDA Advisory Verdict, Boosting Stock Potential, Says BofA Analyst
June 11, 2024
Eli Lilly's donanemab for Alzheimer's disease garners positive FDA committee verdict, prompting analyst's bullish outlook amid comparisons to Biogen's Leqembi.
Via
Benzinga
Exposures
Product Safety
Eli Lilly Drags Alzheimer's Stocks Prothena, Eisai Lower Despite FDA Win
June 11, 2024
An FDA panel unanimously backed Eli Lilly's Alzheimer's drug, but shares of Lilly and its rivals fell Tuesday.
Via
Investor's Business Daily
Exposures
Product Safety
Why Is Eli Lilly Stock Trading Higher Premarket Tuesday?
June 11, 2024
Shares of Eli Lilly surged as an FDA advisory committee endorsed donanemab, an Alzheimer's treatment shown to significantly impact early-stage patients. The drug's benefits outstripped risks, setting...
Via
Benzinga
Exposures
Product Safety
(BIIB) - Analyzing Biogen's Short Interest
June 07, 2024
Via
Benzinga
Deep Dive Into Biogen Stock: Analyst Perspectives (17 Ratings)
May 22, 2024
Via
Benzinga
How Is The Market Feeling About Biogen?
May 20, 2024
Via
Benzinga
Eli Lilly Rises Again, As FDA Panel Mulls Biogen-Rivaling Alzheimer's Drug
June 10, 2024
The FDA isn't bound by the committee's recommendation, but often follows it.
Via
Investor's Business Daily
Exposures
Product Safety
The 3 Most Undervalued Pharma Stocks to Buy in June 2024
June 06, 2024
These undervalued pharma stocks to buy are worth a look because even when the economy is struggling, consumers need key medicines.
Via
InvestorPlace
Topics
Economy
Exposures
Economy
Biogen Shares Surge Following Collaboration With Delta Flight Products: What You Need To Know
June 03, 2024
Biogen Inc. (NASDAQ: BIIB) shares saw a notable uptick Monday afternoon, trading higher after the company revealed a new partnership with Delta Flight Products (DFP) to enhance air travel accessibility...
Via
Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
June 03, 2024
Via
Benzinga
Europe Approves Biogen's Tofersen For Adult Patients With Rare Type Of Neurodegenerative Disorder
May 31, 2024
The European Commission has granted exceptional marketing authorization for Biogen's Qalsody (tofersen), the first EU-approved treatment targeting the genetic cause of ALS.
Via
Benzinga
The Analyst Landscape: 27 Takes On Biogen
April 29, 2024
Via
Benzinga
Will Earnings Cheer Continue To Buoy Markets? Apple, Amazon, Pfizer, Coinbase Lead Flurry Of Q1 Reports This Week
April 29, 2024
With the earnings season now halfway through, the percentage of S&P 500 companies reporting positive earnings surprises and the magnitude of earnings surprises were above their 10-year averages.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
These Analysts Revise Their Forecasts On Biogen After Q1 Results
April 25, 2024
Via
Benzinga
Larimar Therapeutics' Friedreich's Ataxia Investigational Drug Differentiated From Biogen's Marketed Drug
May 21, 2024
Larimar Therapeutics announces FDA lift of partial clinical hold on nomlabofusp (CTI-1601) for Friedreich's Ataxia. Data from Phase 2 study shows well-tolerated treatment with significant frataxin...
Via
Benzinga
Exposures
Product Safety
Large Cap Biopharmaceuticals Performance
May 20, 2024
The biotech sector remains a laggard YTD as can be seen by the IBB.
Via
Talk Markets
Wall Street Favorites: 3 Biotech Stocks with Strong Buy Ratings for May 2024
May 17, 2024
With new innovation, millions of retiring baby boomers, and an increase in mergers, biotech stocks to buy have a good deal of upside ahead.
Via
InvestorPlace
Tale Of Two Ionis-Partnered Neurology-Focused Early Stage Assets-Biogen Discontinues One, Decides Not To Exercise Licensing Option For Another
May 16, 2024
Ionis Pharmaceuticals and Biogen have halted development of BIIB105 for ALS after Phase 1/2 study results showed no impact on key clinical outcomes.
Via
Benzinga
Biogen Stock Continues Its 20% Sprint On A Twist In Alzheimer's Treatment
May 15, 2024
The company is hoping to launch an under-the-skin version of its infusion, Leqembi.
Via
Investor's Business Daily
Jim Cramer Likes Micron And Its CEO, Recommends Buying This Big Bank
May 13, 2024
Jim Cramer recommends buying Micron, adding that he likes the company's CEO Sanjay Mehrotra. As for Fidelis? "Not a favorite."
Via
Benzinga
3 S&P 500 Stocks to Rival Nvidia’s 2023 Performance in the Second Half of 2024
May 11, 2024
Let’s explore three stocks that are well-positioned to rival Nvidia’s growth rates in the second half of 2024.
Via
InvestorPlace
Topics
Stocks
Exposures
US Equities
The 3 Most Undervalued Pharma Stocks to Buy in May 2024
May 09, 2024
Investors looking for good deals in the pharmaceutical industry should watch out for these three undervalued pharma stocks.
Via
InvestorPlace
Why Is Nuvo Group (NUVO) Stock Up 200% Today?
May 06, 2024
Although prenatal care specialist Nuvo Group saw its shares soar on Monday, NUVO stock faces skepticism over its SPAC merger.
Via
InvestorPlace
7 Retirement Stocks to Buy at a 52-Week Low in April
April 29, 2024
One of the best ways to keep your portfolio safe while generating income is with dividend-paying retirement stocks at 52-week lows.
Via
InvestorPlace
Topics
Retirement
Exposures
Pension
Stock Market Rebounds; Tesla, Microsoft, Google, Meta, Chipotle, GE In Focus: Weekly Review
April 26, 2024
Microsoft, Tesla, Google, GE and Chipotle were earnings winners. Meta was a notable loser.
Via
Investor's Business Daily
Meta Platforms To Rally Around 14%? Here Are 10 Top Analyst Forecasts For Thursday
April 25, 2024
Via
Benzinga
Why Biogen Stock Leaped Nearly 5% Higher Today
April 24, 2024
The company came out swinging with its first set of quarterly earnings for this year.
Via
The Motley Fool
Biogen/Eisai's Popular Alzheimer's Drug Leqembi Is Seeing Slow Adoption - Here's Why
April 24, 2024
Discover the challenges facing Leqembi, the first Alzheimer's drug shown to slow progression. Skepticism among doctors and concerns about efficacy and costs hinder widespread adoption despite FDA...
Via
Benzinga
Exposures
Product Safety
< Previous
1
2
3
4
5
6
7
8
9
...
38
39
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.